Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABO and platelet transfusion revisited

J M Heal1, J M Rowe, N Blumberg

  • 1American Red Cross, Rochester Region, NY 14607.

Annals of Hematology
|June 1, 1993
PubMed
Summary

ABO-identical platelets significantly improve transfusion outcomes compared to ABO-unmatched platelets. Reclassifying data using conventional ABO compatibility terms obscured these benefits, suggesting a need to redefine transfusion guidelines for better patient results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

Haem is associated with thrombosis in neonates and infants undergoing cardiac surgery for congenital heart disease.

Vox sanguinis·2017
Same author

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Bone marrow transplantation·2017
Same author

Maresin 1 induces a novel pro-resolving phenotype in human platelets.

Journal of thrombosis and haemostasis : JTH·2017
Same author

The NIST Cold Neutron Research Facility.

Journal of research of the National Institute of Standards and Technology·2017

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Immunology

Background:

  • Historically, ABO compatibility has been considered less critical for platelet transfusions.
  • Previous studies did not observe significant benefits of ABO-identical platelets, potentially due to terminology.
  • The conventional grouping of ABO-identical and ABO-compatible platelets may have masked crucial differences.

Purpose of the Study:

  • To re-evaluate the importance of ABO compatibility in platelet transfusions.
  • To compare corrected count increment (CCI) data using conventional versus ABO-identical terminology.
  • To investigate the impact of ABO-incompatible plasma and cumulative transfusion effects on platelet transfusion success.

Main Methods:

  • Analysis of corrected count increment (CCI) from a previous randomized trial.
  • Re-analysis of transfusion data using conventional ABO compatibility and incompatibility definitions.
  • Classification of transfusions based on the number of previous ABO-incompatible or ABO-identical transfusions.

Main Results:

  • ABO-identical platelets showed a 64% higher mean CCI compared to ABO-unmatched products in the original study.
  • Re-analysis using conventional ABO compatibility/incompatibility terms eliminated the detected benefits of ABO-identical platelets.
  • Increasing numbers of ABO-incompatible transfusions were associated with progressively poorer mean increments, indicating cumulative effects.

Conclusions:

  • The conventional terminology of "ABO compatible" and "ABO incompatible" obscures the significant benefits of ABO-identical platelet transfusions.
  • Transfusion of ABO-incompatible plasma may lead to immune complex formation, indirectly destroying compatible platelets.
  • The cumulative effects of ABO-nonidentical transfusions negatively impact subsequent transfusion success, necessitating a re-evaluation of ABO matching importance.

Related Experiment Videos